To experimentally test the role of TNC in ECM stiffness and glioma aggression, we knocked down TNC in primary GBM cells (WT IDH1, Supplementary Fig. 2h,i) and assessed the resulting effects on ECM stiffness and tumour aggression. This evidence concerns the gene IDH1 and central nervous system cancer.